EYES Second Sight Medical Products Inc

ITEM 7.01 .  REGULATION FD DISCLOSURE

A copy of a slide presentation that Second Sight Medical Products, Inc. ("Second Sight ") intends to use during presentations made before groups and in hosting one-on-one meetings with individuals at the 18 ^th Annual B. Riley Institutional Investor Conference in Santa Monica, California on May 25, 2017 (the "Presentation Materials"), is attached to this Current Report on Form 8-K as Exhibit 99.1 and is incorporated by reference herein.  The Presentation Materials speak as of the date of this Current Report on Form 8-K. While  Second Sight  may elect to update the Presentation Materials in the future or reflect events and circumstances occurring or existing after the date of this Current Report on Form 8-K,  Second Sight specifically disclaims any obligation to do so.  Additionally, Second Sight has posted the Presentation Materials on the Investor Relations section of Second Sight's website: http://investors.secondsight.com. The information contained in this Item 7.01 and Exhibit 99.1 hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by reference in such a filing.